Genpact (G)
(Delayed Data from NYSE)
$39.11 USD
+0.24 (0.62%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $39.12 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Genpact (G) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$37.82 | $43.00 | $33.00 | -2.70% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Genpact comes to $37.82. The forecasts range from a low of $33.00 to a high of $43.00. The average price target represents a decline of 2.7% from the last closing price of $38.87.
Analyst Price Targets (11)
Broker Rating
Genpact currently has an average brokerage recommendation (ABR) of 2.58 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 2.75 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 16.67% and 8.33% of all recommendations. A month ago, Strong Buy made up 16.67%, while Buy represented 8.33%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/G.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 9 | 9 | 8 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 1 | 1 | 1 |
ABR | 2.58 | 2.58 | 2.75 | 2.75 | 2.75 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | BMO Capital Markets | Keith Bachman | Hold | Hold |
8/9/2024 | Cowen & Co. | Bryan Bergin | Hold | Hold |
8/9/2024 | Needham & Company | Mayank Tandon | Moderate Buy | Moderate Buy |
6/17/2024 | Mizuho SecuritiesUSA | Sean M Kennedy | Hold | Hold |
5/10/2024 | Wedbush Securities | Moshe Katri | Hold | Hold |
5/10/2024 | William Blair | Maggie Nolan | Strong Buy | Strong Buy |
4/22/2024 | Not Identified | Not Identified | Hold | Hold |
12/15/2023 | Robert W. Baird & Co. | David J Koning | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.58 |
ABR (Last week) | 2.58 |
# of Recs in ABR | 12 |
Average Target Price | $37.82 |
LT Growth Rate | 8.40% |
Industry | Outsourcing |
Industry Rank by ABR | 45 of 253 |
Current Quarter EPS Est: | 0.81 |